NPI: 1457329799 · ST PETERSBURG, FL 33705 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,478 | $1.62M |
| 2019 | 26,529 | $3.05M |
| 2020 | 23,446 | $3.29M |
| 2021 | 19,308 | $1.28M |
| 2022 | 7,710 | $573K |
| 2023 | 1,573 | $121K |
| 2024 | 600 | $41K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 31,693 | 1,303 | $3.37M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 29,096 | 1,656 | $3.22M |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,523 | 755 | $1.37M |
| A4657 | Syringe, with or without needle, each | 3,791 | 1,384 | $672K |
| J1756 | Injection, iron sucrose, 1 mg | 6,908 | 1,189 | $558K |
| 85041 | 2,048 | 1,059 | $179K | |
| 85048 | 1,904 | 990 | $176K | |
| 83970 | 1,046 | 565 | $98K | |
| 82728 | 777 | 452 | $71K | |
| 83550 | 798 | 460 | $68K | |
| 83540 | 799 | 461 | $68K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 568 | 224 | $48K |
| 82108 | 250 | 148 | $25K | |
| 82607 | 193 | 122 | $18K | |
| 82746 | 189 | 116 | $17K | |
| G0008 | Administration of influenza virus vaccine | 43 | 26 | $8K |
| 90674 | 18 | 14 | $5K |